Our expansive research facilities, state-of-the-art technologies and unique location within The Royal Children’s Hospital, are some of the reasons we’re home to over 1,800 leading researchers and scientists.
Stay informed with the latest research insights, technological advancements and innovations in child health from our research and scientific community.
Discover how you can support us and our partners to help our researchers make life-changing breakthroughs for children.
Search throughout the entire MCRI website to find exactly what you are looking for.
This study evaluates multiple treatments for sepsis under a single platform using adaptive methods. This means that treatments can be adjusted over time based on the data collected and ensures all study participants receive the best and most evidence-based care.
GenV is a research initiative designed to advance health and wellbeing in smarter and faster ways, designed to answer multiple questions such as preterm birth, mental illness, obesity, learning, allergies and more.
Would you like to make this gift in honour or support of someone?
If you’re interested in being part of the world’s largest study on the off-target effects of Bacille Calmette-Guérin (BCG) vaccine, you’re in the right place. Based at Murdoch Children’s Research Institute, the BRACE trial has some exciting clinical and immunological PhD projects.
The Murdoch Children’s Research Institute (MCRI) has been awarded a new grant for a project that aims to better address the health care and service needs of adolescents and young adults with cerebral palsy.Researcher Megan Walsh secured the $19,951 funding under The State Trustees Australia
Kidney disease (also called renal disease) is a general term for when the kidneys don’t work properly, causing waste to build up in the body.
Our study aims to assess the immune responses of two different fourth-dose vaccines (bivalent Moderna versus Novavax) among people who have previously received three doses of a COVID-19 vaccine.
This study will develop a reference atlas of healthy cells in the paediatric airway in order to understand the changes caused by childhood lung disease.
This trial is testing Intranasal Heparin to treat early COVID-19 infection.
This study is completed. This study brought an understanding and greater clarity on the complex topic of consent in research involving children.
Page 133 of 223
